Perspective Therapeutics, Inc. — Cash Flow Charts
52 quarters of history · ending 2023-09-30 · SEC EDGAR
Source:10-K · 10-Q
Capital Allocation
How management deploys cash: investing in the business (Capex + M&A) vs returning to shareholders (Buybacks + Dividends).
Capital Allocation Waterfall
Buybacks vs Stock-Based Comp
Cash Flow
Cash Flow by Activity
Operating Cash Flow↓-582.8% -$8M
$-10M
Free Cash Flow↑+87.7% +$2M
$-227K
Investing Cash Flow↑+97261.5% +$25M
$25M
Financing Cash Flow↓-96.4% -$27K
$1K
Capex↑+152.2% +$137K
$227K
Stock-Based Comp↓-3.0% -$14K
$451K
D&A↑+286.6% +$192K
$259K
SBC Allocated Expense↓-10.1% -$47K
$418K
SBC Unrecognized Cost↓-100.0% -$2M
$0